logo

For the Inventor, By the Inventor

Waterford, CT, United States of America

Jun Xiao

This inventor holds 8 USPTO granted patents and 9 published patent applications and 2 EPO patents. Top assignees: Pfizer Corporation, Pfizer Products Inc., Other. Active years: 2010-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jun Xiao. Retrieved from https://idiyas.com/inventor/jun-xiao-g2b8i46g

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 

% Patents Active = 87.5

 

Average Co-Inventor Count = 9.0

ph-index = 4

Forward Citations = 64(Granted Patents)


Location History:

  • Waterford, CT (US) (2010 - 2019)
  • East Lyme, CT (US) (2022 - 2024)

Company Filing History:

goldMedal7 out of 4,488 
 
Pfizer Corporation
 patents
silverMedal1 out of 47 
 
Pfizer Products Inc.
 patents
bronzeMedal1 out of 834,513 
Other
 patents
where one patent can have more than one assignee

Years Active: 2010-2026

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents
1. 12637461 - Compounds for the activation of AMPK (2026-05-26),
2. 11976064 - Toll-like receptor agonists (2024-05-07),
3. 11339159 - Toll-like receptor agonists (2022-05-24),
4. 10450297 - Sulfonyl amide derivatives for the treatment of abnormal cell growth (2019-10-22),
5. 8440822 - Sulfonyl amide derivatives for the treatment of abnormal cell growth (2013-05-14),
6. 8247411 - Sulfonyl amide derivatives for the treatment of abnormal cell growth (2012-08-21),
7. 7928109 - Sulfonyl amide derivatives for the treatment of abnormal cell growth (2011-04-19),
8. 7820648 - Pyrimidine derivatives for the treatment of abnormal cell growth (2010-10-26),

Title: Jun Xiao: Innovator in Pharmaceutical Compounds

Introduction

Jun Xiao is a prominent inventor based in Waterford, CT (US), known for his significant contributions to the field of pharmaceuticals. He holds a total of 7 patents, showcasing his innovative approach to developing new treatments for various medical conditions.

Latest Patents

Among his latest patents, Jun Xiao has developed toll-like receptor agonists. These inventions relate to imidazo-pyridinyl compounds, or pharmaceutically acceptable salts thereof. His work includes pharmaceutical compositions comprising such compounds and salts, as well as methods for using these compounds, salts, and compositions for treating abnormal cell growth, including cancer, in a subject.

Career Highlights

Throughout his career, Jun Xiao has made notable advancements in pharmaceutical research. His expertise has led to the development of groundbreaking treatments that address critical health issues. His work is recognized for its potential impact on cancer therapies.

Collaborations

Jun Xiao has collaborated with esteemed professionals in the field, including Michael Luzzio and Samit Kumar Bhattacharya. These partnerships have contributed to the success of his innovative projects.

Conclusion

Jun Xiao's contributions to pharmaceutical innovations highlight his dedication to improving healthcare through research and development. His patents reflect a commitment to finding effective treatments for serious medical conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…